ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 68 filers reported holding ACUMEN PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $64,101 | +1022.4% | 26,488 | +1778.6% | 0.00% | – |
| Q1 2024 | $5,711 | -94.9% | 1,410 | -95.2% | 0.00% | -100.0% |
| Q4 2023 | $111,702 | +1164.9% | 29,089 | +1267.0% | 0.00% | – |
| Q3 2023 | $8,831 | -48.6% | 2,128 | -40.5% | 0.00% | -100.0% |
| Q2 2023 | $17,196 | +143200.0% | 3,575 | +18.3% | 0.00% | – |
| Q1 2023 | $12 | -33.3% | 3,022 | -7.6% | 0.00% | -100.0% |
| Q4 2022 | $18 | -100.0% | 3,272 | -59.7% | 0.00% | 0.0% |
| Q3 2022 | $81,000 | +350.0% | 8,117 | +108.9% | 0.00% | – |
| Q2 2022 | $18,000 | +80.0% | 3,885 | +52.1% | 0.00% | – |
| Q1 2022 | $10,000 | -77.3% | 2,555 | -60.8% | 0.00% | -100.0% |
| Q4 2021 | $44,000 | +340.0% | 6,523 | +838.6% | 0.00% | – |
| Q3 2021 | $10,000 | – | 695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $13,121,568 | 3.65% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,253,478 | 1.30% |
| RA Capital Management | 14,932,063 | $57,339,122 | 0.90% |
| Parkman Healthcare Partners LLC | 603,497 | $2,317,428 | 0.33% |
| Rock Springs Capital Management LP | 2,300,059 | $8,832,227 | 0.22% |
| Ikarian Capital, LLC | 315,265 | $1,210,617 | 0.11% |
| CATALYST FINANCIAL PARTNERS LLC | 89,699 | $344,444 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 246,895 | $948,077 | 0.09% |
| Laurion Capital Management LP | 1,895,023 | $7,276,888 | 0.06% |
| Intrepid Financial Planning Group LLC | 30,150 | $115,776 | 0.06% |